Terminology challenges: Defining modifie
β
Marilyn N. Martinez; Danielle Lindquist; Sanja Modric
π
Article
π
2010
π
John Wiley and Sons
π
English
β 169 KB
Terminologies for describing dosage form release characteristics for human pharmaceuticals have been addressed by bodies such as the US Food and Drug Administration (FDA), the International Conference on Harmonization (ICH), and the US Pharmacopeia (USP). While the definition for terms such as ''imm